Faculty Interview

kevin outterson

Clinical Trial Transparency—Antidote to Weaker Off-Label-Promotion Rules?

New England Journal of Medicine interviews Kevin Outterson about his paper on the FDA’s guidance on off-label promotion and the move toward clinical trial transparency.

Faculty POV

wendy mariner

Hobby Lobby and Corporate Personhood at the Expense of Women

Writing for the Health Law Professor Blog, Wendy Mariner takes issue with the court’s continuing “legal fiction” of extending the benefits of personhood to corporations.